One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A Pill for Sexual Desire in Female Cancer Survivors: Too Good to Be True?.
Lustberg, Maryam B. MD, MPH 1,,; Loprinzi, Charles L. MD 2,; Streicher, Lauren MD 3,
doi : 10.1200/JCO.21.02654
Volume 40(4) pgs. 317-431 February 1, 2022
How Strong Is the Evidence Supporting Thromboprophylaxis in Surgical Oncology?.
Klemen, Nicholas D. MD 1,; Feingold, Paul L. MD 2; Hashimoto, Barry PhD 3
doi : 10.1200/JCO.21.01934
Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.
Barton, Debra L. RN, PhD 1,,; Pugh, Stephanie L. PhD 2,; Ganz, Patricia A. MD 3,; Plaxe, Steven C. MD 4,; Koontz, Bridget F. MD 5,; Carter, Jeanne PhD 6; Greyz-Yusupov, Natalya MD 7; Page, Seth J. MD 8; Rowland, Kendrith M. Jr MD 9; Balcueva, Ernie P. MD 10; Nabeel, Sobia MD 11; Basil, Jack B. MD 12; Hill, Matthew L. DO 13,; Muller, Carolyn Y. MD 14,; Bell, Maria C. MD 15; Deshmukh, Snehal MS 2; Kachnic, Lisa A. MD 16,
doi : 10.1200/JCO.21.01473
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.
Furman, Wayne L. MD 1,; McCarville, Beth MD 2; Shulkin, Barry L. MD 2,; Davidoff, Andrew MD 2; Krasin, Matthew MD 2,; Hsu, Chia-Wei MS 2; Pan, Haitao PhD 2; Wu, Jianrong PhD 3; Brennan, Rachel MD 1; Bishop, Michael W. MD 1,; Helmig, Sara MD 1; Stewart, Elizabeth MD 1; Navid, Fariba MD 4,; Triplett, Brandon MD 2,; Santana, Victor MD 2; Santiago, Teresa MD 2; Hank, Jacquelyn A. PhD 5; Gillies, Stephen D. PhD 6,; Yu, Alice MD, PhD 7,8,; Sondel, Paul M. MD, PhD 5,; Leung, Wing H. MD, PhD 9,; Pappo, Alberto MD 1,; Federico, Sara M. MD 1
doi : 10.1200/JCO.21.01375
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.
Schneider, Bryan P. MD 1,,; Jiang, Guanglong MS 1; Ballinger, Tarah J. MD 1,; Shen, Fei MD 1; Chitambar, Christopher MD 2; Nanda, Rita MD 3,; Falkson, Carla MBBch, PhD 4,; Lynce, Filipa C. MD 5,; Gallagher, Christopher MD 5,; Isaacs, Claudine MD 5,; Blaya, Marcelo MD 6; Paplomata, Elisavet MD 7,; Walling, Radhika MD 8,; Daily, Karen DO 9,; Mahtani, Reshma DO 10,; Thompson, Michael A. MD, PhD 11,; Graham, Robert MD 12; Cooper, Maureen E. BS 13,; Pavlick, Dean C. BS 13,; Albacker, Lee A. PhD 13,; Gregg, Jeffrey MD 13,14,; Solzak, Jeffrey P. MS, MBA 1; Chen, Yu-Hsiang PhD 1,; Bales, Casey L. MS 1; Cantor, Erica MS 1; Hancock, Bradley A. BS 1,; Kassem, Nawal MD 1; Helft, Paul MD 1; O'Neil, Bert MD 1,; Storniolo, Anna Maria V. MD 1,; Badve, Sunil MBBS 1,; Miller, Kathy D. MD 1,; Radovich, Milan PhD 1,
doi : 10.1200/JCO.21.01657
Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.
Luznik, Leo MD 1,; Pasquini, Marcelo C. MD, MS 2,,; Logan, Brent PhD 2,; Soiffer, Robert J. MD 3,; Wu, Juan PhD 4; Devine, Steven M. MD 5,; Geller, Nancy PhD 6; Giralt, Sergio MD 7,; Heslop, Helen E. MD 8,; Horowitz, Mary M. MD, MS 2,; Jones, Richard J. MD 1; Litzow, Mark R. MD 9,; Mendizabal, Adam PhD 4; Muffly, Lori MD 10,; Nemecek, Eneida R. MD 11,; O'Donnell, Lynn PhD 12; O'Reilly, Richard J. MD 7,; Palencia, Raquel PharmD 13; Schetelig, Johannes MD 13,; Shune, Leyla MD 14; Solomon, Scott R. MD 15; Vasu, Sumithira MD 12,; Ho, Vincent T. MD 3,; Perales, Miguel-Angel MD 7,
doi : 10.1200/JCO.21.02293
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.
Shouval, Roni MD, PhD 1,2,,; Alarcon Tomas, Ana MD 1,3; Fein, Joshua A. MD 4; Flynn, Jessica R. MSc 5; Markovits, Ettai MD 6; Mayer, Shimrit MSc 7; Olaide Afuye, Aishat BA 1; Alperovich, Anna MD 1; Anagnostou, Theodora MD 1,8; Besser, Michal J. PhD 6,9,; Batlevi, Connie Lee MD 2,10,; Dahi, Parastoo B. MD 1,2,; Devlin, Sean M. PhD 5,; Fingrut, Warren B. MD 1; Giralt, Sergio A. MD 1,2,; Lin, Richard J. MD 1,2,; Markel, Gal MD, PhD 9,11,; Salles, Gilles MD 2,10,; Sauter, Craig S. MD 1,2,; Scordo, Michael MD 1,2,; Shah, Gunjan L. MD 1,2,; Shah, Nishi MD 1; Scherz-Shouval, Ruth PhD 7; van den Brink, Marcel MD, PhD 1,2,; Perales, Miguel-Angel MD 1,2,; Palomba, Maria Lia MD 2,10,
doi : 10.1200/JCO.21.02143
Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181.
Adenis, Antoine MD, PhD 1,,; Kulkarni, Amit S. PhD 2,; Girotto, Gustavo C. MD 3,; de la Fouchardiere, Christelle MD 4,; Senellart, Helene MD 5; van Laarhoven, Hanneke W. M. MD, PhD 6,; Mansoor, Wasat MBChB, MRCP, PhD 7,; Al-Rajabi, Raed MD 8,; Norquist, Josephine MS 2,; Amonkar, Mayur PhD 2,; Suryawanshi, Shailaja PhD 2,; Bhagia, Pooja MBBS, MD 2,; Metges, Jean-Philippe MD, Msc 9,
doi : 10.1200/JCO.21.00601
Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma.
Zhao, Joseph J. 1; Yap, Dominic Wei Ting 1; Chan, Yiong Huak PhD 2; Tan, Benjamin Kye Jyn 1; Teo, Chong Boon 1; Syn, Nicholas L. MBBS 1; Smyth, Elizabeth C. MD 3,; Soon, Yu Yang MBBS (Hons) 4,; Sundar, Raghav MBBS, PhD 1,5,6,7,8,,
doi : 10.1200/JCO.21.01862
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.
Mohile, Nimish A. MD 1,; Messersmith, Hans MPH 2; Gatson, Na Tosha MD, PhD 3,4,; Hottinger, Andreas F. MD, PhD 5,; Lassman, Andrew MD 6,; Morton, Jordan MD 7; Ney, Douglas MD 8,; Nghiemphu, Phioanh Leia MD 9,; Olar, Adriana MD 10,; Olson, Jeffery MD 11,; Perry, James MD 12; Portnow, Jana MD 13; Schiff, David MD 14,; Shannon, Anne MA 15; Shih, Helen A. MD, MS 16,; Strowd, Roy MD, MEd, MS 17,; van den Bent, Martin MD, PhD 18,; Ziu, Mateo MD, MBA 19,; Blakeley, Jaishri MD 20,
doi : 10.1200/JCO.21.02036
Evaluating the Association of Adverse Events and Patient-Reported Symptoms to Endocrine Therapy Tolerability.
Henry, N. Lynn MD, PhD; Rogatko, Andre PhD; Ganz, Patricia A. MD
doi : 10.1200/JCO.21.02387
